Use access key #2 to skip to page content.
$8.97 0.00 (0.00%)
10/16/2008 4:00 PM

Tercica, Inc. (TRCA)

CAPS Rating:
*

A biopharmaceutical company focuses on the development and commercialization of new therapeutics for the treatment of short stature and other endocrine disorders.

View All Commentary (TRCA)

Recs

0

Avatar bmaple00 (54.56) Submitted: 6/05/08 7:34 PM : Outperform Start Price: $8.78 TRCA Score: 39.97

This one has been on my watch list, I should have rated this one a day earlier.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links